Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Inflammatory Bowel Diseases

Free Subscription 02.02.2026 2 Aliment Pharmacol Ther 1 BMC Gastroenterol 2 Dig Dis Sci 1 Eur J Gastroenterol Hepatol 3 Gastroenterology 1 Gut 2 Inflamm Bowel Dis 1 J Crohns Colitis 1 Mediators Inflamm 2 PLoS One 1 Z Gastroenterol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Aliment Pharmacol Ther

1. PATIL AN, Kumar A, Sharma V
   Letter: A Patient Centric Approach to Tapering Steroids in Steroid Responsive Moderate to Severely Active Ulcerative Colitis. Authors' Reply.
   Aliment Pharmacol Ther. 2026 Jan 29. doi: 10.1111/apt.70552.
   PubMed        
   
   
2. BHAT G, Shetty A
   Letter: A Patient Centric Approach to Tapering Steroids in Steroid Responsive Moderate to Severely Active Ulcerative Colitis.
   Aliment Pharmacol Ther. 2026 Jan 28. doi: 10.1111/apt.70546.
   PubMed        
   
   

   
   BMC Gastroenterol

3. QIU R, Zhang M, Li T, Liang Y, et al
   Exploring genotype-phenotype correlations in three pediatric patients with IL10RA variants and very early-onset inflammatory bowel disease.
   BMC Gastroenterol. 2026 Jan 28. doi: 10.1186/s12876-026-04648.
   PubMed        
   
   

   
   Dig Dis Sci

4. DING Z, Tang G, Yan Y, Yang Y, et al
   A Case of Ulcerative Colitis Combined with Pulmonary Air Leak Syndrome.
   Dig Dis Sci. 2026 Jan 28. doi: 10.1007/s10620-026-09671.
   PubMed        
   
   
5. MCSHANE C, O'Connell F, Kevans D, O'Sullivan J, et al
   Ex Vivo Human Colonic Explants Identify Metabolic Alterations and Cytokine Dysregulation in Ulcerative Colitis: A Pilot Study.
   Dig Dis Sci. 2026 Jan 26. doi: 10.1007/s10620-025-09665.
   PubMed         Abstract available
   
   

   
   Eur J Gastroenterol Hepatol

6. GALTS CPC, Anvari S, Haq M, Grossman K, et al
   Second-line infliximab therapy for ulcerative colitis (SLIT-UC): a retrospective cohort study.
   Eur J Gastroenterol Hepatol. 2026 Jan 13. doi: 10.1097/MEG.0000000000003132.
   PubMed         Abstract available
   
   

   
   Gastroenterology

7. COHEN-MEKELBURG S, Hashash JG, Loftus EV Jr, Rubin DT, et al
   AGA Clinical Practice Update on Inpatient Management of Adults With Inflammatory Bowel Disease: Expert Review.
   Gastroenterology. 2026;170:408-417.
   PubMed         Abstract available
   
   
8. YE Y, Yang J, Shang Y, Wang W, et al
   Dietary Flexibility as a Pathway to Nutritional Remission in Crohn's Disease.
   Gastroenterology. 2026 Jan 23:S0016-5085(26)00035.
   PubMed        
   
   
9. CHEN F
   Reconsidering the Microbiome and Maintenance Claims in Whole-Food Dietary Trials for Crohn's Disease.
   Gastroenterology. 2026 Jan 23:S0016-5085(26)00034.
   PubMed        
   
   

   
   Gut

10. IACUCCI M, Zammarchi I, Pugliano CL, Santacroce G, et al
    Shaping the future of postoperative recurrence in Crohn's disease: personalised approaches with AI-enabled imaging and multi-omics.
    Gut. 2026 Jan 27:gutjnl-2025-337171. doi: 10.1136/gutjnl-2025-337171.
    PubMed         Abstract available
    
    

    
    Inflamm Bowel Dis

11. GILLILAND A, Chen Y, Ng I, Han X, et al
    Biopsy-derived colonoid air-liquid interface monolayers reveal persistent mucosal defects in ulcerative colitis patients.
    Inflamm Bowel Dis. 2026 Jan 27:izaf318. doi: 10.1093.
    PubMed         Abstract available
    
    
12. SAAGER ES, Lutter L, Mahmmod N, Delemarre EM, et al
    Distinct Effects of Autologous Hematopoietic Stem Cell Transplantation on T Cell Composition and Profile in Refractory Crohn's Disease.
    Inflamm Bowel Dis. 2026 Jan 26:izaf331. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Crohns Colitis

13. QURAISHI MN, Moakes CA, Yalchin M, Blackwell C, et al
    Mechanistic insights into FMT for the treatment of ulcerative colitis: analysis of the STOP-Colitis trial.
    J Crohns Colitis. 2026 Jan 23:jjag006. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Mediators Inflamm

14. SHEN F, Sun K, Song J, Chen X, et al
    Robinia pseudoacacia L. Flower Exosome-Like Nanoparticles (RFELNs) Activate AhR/IL-22 to Relieve Intestinal Barrier Dysfunction Through Regulating Gut Microbiota-Interrelated Tryptophan Metabolism in Ulcerative Colitis Mice.
    Mediators Inflamm. 2026;2026:1794173.
    PubMed         Abstract available
    
    

    
    PLoS One

15. WOLFF A, Feneberg E, Shakhtour J, Steiger K, et al
    Retrospective analysis of neurofilament-light chain in patients with inflammatory bowel disease - A pilot study.
    PLoS One. 2026;21:e0340182.
    PubMed         Abstract available
    
    
16. FABIAN O, Bajer L, Macinga P, Brezina J, et al
    Identifying biomarkers for diagnosis and disease activity monitoring in PSC-IBD and UC through proteomic profiling: A prospective, biomarker discovery single-center study protocol.
    PLoS One. 2026;21:e0341885.
    PubMed         Abstract available
    
    

    
    Z Gastroenterol

17. ZECHER BF, Schramm C
    [Immunopathogenesis and therapy of primary sclerosing cholangitis].
    Z Gastroenterol. 2026;64:56-66.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.